Names | |
---|---|
IUPAC name
(3E)-1,7,7-Trimethyl-3-[(4-methylphenyl)methylene]-2-norbornanone
| |
Other names
4-Methylbenzylidene camphor
3-(4-Methylbenzylidene)bornan-2-one 3-(4-Methylbenzylidene)-dl-camphor | |
Identifiers | |
3D model (JSmol)
|
|
Abbreviations | 4-MBC |
ChemSpider | |
ECHA InfoCard | 100.048.386 |
EC Number |
|
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C18H22O | |
Molar mass | 254.37 g/mol |
Appearance | White crystalline powder |
Melting point | 66 to 69 °C (151 to 156 °F; 339 to 342 K) |
Insoluble | |
Hazards | |
GHS labelling: | |
Warning | |
H410 | |
P273, P391, P501 | |
Pharmacology | |
Legal status |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Enzacamene (INN; also known as 4-methylbenzylidene camphor or 4-MBC) is an organic camphor derivative that is used in the cosmetic industry for its ability to protect the skin against UV, specifically UV B radiation. As such, it is used in sunscreen lotions and other skincare products claiming a SPF value. Its tradenames include Eusolex 6300 (Merck) and Parsol 5000 (DSM).